Rigel Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

RIGL 3.07 +0.09 (3.02%)
price chart
Company Shares of Rigel Pharmaceuticals, Inc. Rally 1.36%
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) appreciated by 1.36% during the past week but lost 2.3% on a 4-week basis.
Rigel Pharmaceuticals (RIGL) Scheduled to Post Earnings on Tuesday  WKRB News
Why Shares of Rigel Pharmaceuticals Inc. Exploded Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Pharmalot, Pharmalittle: We're Reading About Merck, Valeant and Much More!!  Wall Street Journal (blog)
Rigel Pharmaceuticals (RIGL) Set to Announce Earnings on Tuesday
Rigel Pharmaceuticals (NASDAQ:RIGL) last issued its earnings results on Thursday, May 7th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.18) by $0.03.
Company Shares of Rigel Pharmaceuticals, Inc. Rally 6.19%
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) appreciated by 6.19% during the past week but lost 6.59% on a 4-week basis.
Rigel Pharmaceuticals Upgraded by Zacks to Hold (RIGL)  Dakota Financial News
Rigel Welcomes Keith A. Katkin to Board of Directors  PR Newswire (press release)
Rigel Pharmaceuticals Inc. (RIGL) Jumps 5.3% on July 31
Rigel Pharmaceuticals Inc. (RIGL) was among the biggest gainers on the Russell 2000 for Friday July 31 as the stock popped 5.3% to $2.98, representing a gain of $0.15 per share.
Here's Why Rigel Pharmaceuticals, Inc. (RIGL) Stock Is Trading Up By 37% Today
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) will collaborate for the finding, marketing, and development of cancer immunotherapies with Bristol-Myers Squibb Co (NYSE:BMY), according to a press release reported on Monday.
Is Rigel Getting Enough From Bristol-Meyers?  24/7 Wall St.
Rigel and Bristol-Myers Squibb Announce Research and Development ...  PR Newswire (press release)
Company Shares of Rigel Pharmaceuticals, Inc. Drops by -6.44%
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has lost 6.44% during the past week and dropped 17.12% in the last 4 weeks.
Big News Gains: Rigel Pharmaceuticals (NASDAQ:RIGL), The Boeing (NYSE:BA ...  Property Mentor
Disappointments, New Prospects for Rigel Pharmaceuticals
When Rigel Pharmaceuticals of South San Francisco took the stage at the annual JP Morgan Healthcare conference in January, the 16-year-old biotechnology company hoped to soon introduce its first two approved drugs—both of them designed to treat ...
Related articles »  
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers
Rigel Pharmaceuticals Inc. has fallen short of the finish line in a couple of highly spectacular instances. First, there was the drug fostamatinib, which in 2012 failed in a late-stage trial by AstraZeneca plc (NYSE: AZN) as a potential rheumatoid ...
Company Shares of Rigel Pharmaceuticals, Inc. Drops by -6.96%
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has lost 6.96% during the past week and dropped 9.82% in the last 4 weeks.